Representative peer-reviewed publications

Co-first author; Corresponding author

• Li J, Liu W, Mojumdar K, Kim H, Zhou Z, Ju Z, Kumar SV, Ng P, Chen H, Davies MA, Lu Y, Akbani R, Mills GB, Liang H (2024)
  A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
  Nature Cancer 5(10):1579-1595 [PDF]
• Luo Y, Xia Y, Liu D, Li X, Li H, Liu J, Zhou D, Dong Y, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L, the COCPO Consortium, Ma D, Fang Y, Liang H , Gao Q (2024)
  Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors
  Cell 187(18):4905-4925 [PDF]
• Zhou Z, Chen MM, Luo Y, Mojumdar K, Peng X, Chen H, Kumar S, Akbani R, Lu Y, Liang H (2022)
  Tumor-intrinsic SIRPA Promotes Sensitivity to Checkpoint Inhibition Immunotherapy in Melanoma
  Cancer Cell 40(11):1324-1340 [PDF]
• Li J, Chen H, Wang Y, Chen MM, Liang H (2021)
  Next-generation analystics for omics data
  Cancer Cell 39(1): 3-6 [PDF]
• Zhao W, Li J, Chen MM, Luo Y, Ju Z, Nesser NK, Johnson-Camacho K, Boniface CT, Lawrence Y, Pande NY, Spellman PT, Davies MA, Herlyn M, Gray JW, von Euw E, Slamon DJ, Schultz A, Kumar SV, Korkut A, Akbani R, Lu Y, Brugge JS, Mills GB, Liang H (2020)
  Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines
  Cancer Cell 38(6): 829-843 [PDF]
• Chen H, Liang H (2020)
  A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer
  Cancer Cell 38(5): 701-715 [PDF]
• Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim H-L, Nakagawa H, Park K, Campbell PJ, Liang H; PCAWG Consortium (2020)
  Comprehensive Molecular Characterization of Mitochondrial Genomes in Human Cancers
  Nature Genetics 52 (3): 342-352 [PDF]
• Chen H, Li C, Peng X, Zhou Z, Weinstein JN, The Cancer Genome Atlas Research Network, Liang H (2018)
  A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples
  Cell 173(2):386-399 [PDF]
• Li J, Zhao W, Akbani R, Liu W, Ju Z, Ling S, Vellano CP, Roebuck P, Yu Q, Eterovic AK, Byers LA, Davies MA, Deng W, Vashisht Gopal YN, Chen G, von Euw EM, Slamon D, Conklin D, Heymach JV, Minna JD, Myers JN, Lu Y, Mills GB, Liang H (2017)
  Characterization of human cancer cell lines by reverse phase protein arrays
  Cancer Cell 31(2): 225-239 [PDF]
• Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao H, Li J, Mills GB, Shu Y, Li L, Liang H (2016)
  Comprehensive characterization of molecular differences in cancer between male and female patients
  Cancer Cell 29(5): 711-722 [PDF]
• Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y , Werner HM, Eterovic KA, Yuan Y, Li J, Nair N, Minelli R, Tsang Y, Cheung LW, Jeong KJ, Roszik J, Ju Z, Woodman S, Lu Y, Scott KL, Li JB, Mills GB, Liang H (2015)
  The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers
  Cancer Cell 28(5):515-528 [PDF]
• Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, Byers LA, Xu Y, Hess KR, Diao L, Han L, Huang X, Lawrence MS, Weinstein JN, Stuart JM, Mills GB, Garraway LA, Margolin AA, Getz G, Liang H (2014)
  Assessing the clinical utility of cancer genomic and proteomic data across tumor types
  Nature Biotechnology 32 (7): 644-52 [PDF]
• Li J, Lu Y, Akbani R, Ju Z, Roebuck PL, Liu W, Yang JY, Broom BM, Verhaak RG, Kane DW, Wakefield C, Weinstein JN, Mills GB, Liang H (2013)

  TCPA: a resource for cancer functional proteomics data

  Nature Methods 10 (11): 1046-1047 [PDF]